The erythrocyte catalase enzyme activity in Iranian osteoporotic women

Iranian Journal of Pharmaceutical Sciences

Volumn 6, Issue 1, 2010, Pages 19-24

  Jannat, Behrooz ^a   Oveisi, Mohammad Reza ^b   Sadeghi, Naficeh ^b   Hajimahmoodi, Mannan ^b   Jamshidi, Ahmad Reza ^c   Dolagh, Golnaz Izadi ^b   Behfar, Abdol azim ^d   Gholami, Kheir ollah ^b   Behzad, Masoomeh ^b  

^a MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Catalase activity; Iranian women; Osteoporosis; Oxidative stress

Indexed keywords

CATALASE;

ADULT; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ERYTHROCYTE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OSTEOPENIA; OSTEOPOROSIS;

EID: 78650399080     PISSN: 17352444     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Fatokum AA, Stone TW, Smith RA. Response of different MC3T3-E1 osteoblast like cells to reactive oxygen species. Eur J Pharmacol 2008; 587: 35-41.
2. Chavan S, More U, Mulgund SH, Saxena V, Sontakke A. Effect of supplementation of vitamin C and E on oxidative stress in osteoposis. Indian J Clin Biochem 2007; 22: 101-105.
3. Chin AI. Melatonin and its Role in aging and oxidative stress. Nutr Bytes 1996; 2: issue 1.
4. Masella R, Di Benedetto R, Vari R. Novel mechanism of natural antioxidant compounds is biological system. Involvement of glutathione and glutathione-related enzymes. J Nutr Biochem 2005; 16: 577-586.
5. Ozgocmen S, Kaya H, Fadillioglu E, Aydogan R, Yilmaz Z. Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osterporosis. Mol Cell Biochem 2007; 295: 45-52.
6. Sanchez-Rodriguez M, Ruiz-Ramos M, Correa-Munoz E, Mendoza-Nunez V. Oxidative stress as a risk factor for osteoporosis in elderly Mexican as characterized by antioxidant enzymes. BMC Musculoskelet Disord 2007; 8:124.
7. McCormick K. Osteoporosis: integrating biomarkers and other diagnostic correlates into the management of bone fragility. Markers Oxidative Damage 2007; 1: 1-10.
8. Abei H. Methods of enzymatic analysis. New York: Academic press, 1974; pp. 673-677.
9. Kourie JI. Interaction of reactive oxygen species with ion transport mechanism. Am J Physiol Cell Physiol 1998; 275: 1-24.
10. Isomura H, Fujie K, Shibata K, Inoue N, Iizuka T, Takebe G, Takahashi K, Nishihira J, Izumi H, Sakamoto W. Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology 2004; 197: 93-100.
11. Arai M, Shibata Y, Pugdee K, Abiko Y, Ogata Y. Effects of reactive oxygen species on antioxidant system and osteoblastic differentiation in MC3T3-E1 cells. IUBMB Life 2008; 59: 27-33.
12. Altindag Z, Erel O, Soran N, Celik H, Selek S. Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol Int 2008; 28: 317-321.
13. Costa LG. Biomarkers research in neurotoxicology: the role of mechanistic studies to bridge the gap between the laboratory and epidemiological investigations. Environ Health Persp 1996; 104: 55-62.
14. Leite MF, Ganzerla E, Marques MM, Nicolau J. Diabetes induces metabolic alterations in dental pulp. J Endod 2008; 34: 1211-1214.
15. Masayo F, Makoto K, Yasushi T, Yasuyuki A. Analysis of serum catalase activities in pancreatic disease. J Gastroenterol 2004; 39: 469-474.
16. Miller JD, Chu Y, Brooks RM, Richenbacher WE, Peña-Silva R, Heistad DD. Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. J Am Coll Cardiol 2008; 52: 843-850.
17. Looi ML, Mohd Dali AZ, Md Ali SA, Wan Ngah WZ, Mohd Yusof YA. Oxidative damage and antioxidant status in patients with cervical intraepithelial neoplasia and carcinoma of the cervix. Eur J Cancer Prev 2008; 17: 555-560.
18. Sadeghi N, Oveisi MR, Jannat B, Hajimahmoodi M, Jamshidi AR, Sajadian Z. Determination of plasma gluthatione reductase enzyme activity in osteoporotic women. Daru 2008; 16: 51-54.
19. Oveisi MR, Sadeghi N, Jannat B, Hajimahmoodi M, Hajibabai M, Jamshidi AR, Javadi S, Korouji M. The relation of the plasma ascorbic acid and bone mineral density in women referring to Jami clinic, Tehran, Iran. IJPS 2008;4:249-254.
20. Hajimahmoodi M, Sadeghi N, Hajibabai M, Jannat B, Jamshidi AR, Mirabzadeh M. Vitamin E plasma concentration in osteoprotic patients. Tehran U Med J 2007;65:79-85.
21. Behfar AA, Sadeghi N, Oveisi MR, Jannat B, Hajimahmoodi M, Jamshidi AR, Rastegary P. The plasma antioxidant activity of enzyme activity in osteoporotic women. Acta Med Iranica 2008; 46:441-446.
22. Yang Z, Zhang Z, Penniston KL, Binkley N, Tanumihardjo SA. Serum carotenoid concentrations in postmenopausal women from the United States with and without osteoporosis. Int J Vitam Nutr 2008; 78: 105-111.
23. Rao LG, Mackinnon ES, Rao AV. Lycopene intake significantly reduces biomarkers oxidative stress and bone resorption in postmenopausal women. Acta Horticulturae 2007; 18: 109-115.
24. Knight JA. Disease related to oxygen-derived free radicals. Ann Clin Lab Sci 1995; 25: 111-121.